Helicobacter : Impact Factor & More
eISSN: 1523-5378pISSN: 1083-4389
Share this on:
Key Metrics
CiteScore 
8.6
Eigenfactor
0.001 - 0.005
H-Index
87
Impact Factor
< 5
SJR
Q1Gastroenterology
SNIP
1.62
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Helicobacter
Helicobacter Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1996 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Helicobacter ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Helicobacter
Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial.
- 1 Feb 2026
- Helicobacter
Non-Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis.
- 1 Feb 2026
- Helicobacter
EUROHELICAN-Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication.
- 1 Feb 2026
- Helicobacter
Drug Repurposing Identifies Natamycin and Avacopan as Urease-Targeted Therapeutic Candidates Against Helicobacter pylori.
- 1 Feb 2026
- Helicobacter
An Open‐Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7‐Day Triple Therapy With Bismuth Versus 14‐Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents
- 1 Jan 2026
- Helicobacter
Antibiotic Combinations in Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta-Analysis.
- 1 Nov 2025
- Helicobacter
Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial.
- 1 Feb 2026
- Helicobacter
Non-Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis.
- 1 Feb 2026
- Helicobacter
EUROHELICAN-Accelerating Gastric Cancer Reduction Through Helicobacter pylori Eradication.
- 1 Feb 2026
- Helicobacter
Drug Repurposing Identifies Natamycin and Avacopan as Urease-Targeted Therapeutic Candidates Against Helicobacter pylori.
- 1 Feb 2026
- Helicobacter
An Open‐Label Randomized Controlled Trial Comparing the Efficacy and Safety of a 7‐Day Triple Therapy With Bismuth Versus 14‐Day Standard Triple Therapy for Helicobacter pylori Eradication in Children and Adolescents
- 1 Jan 2026
- Helicobacter
Antibiotic Combinations in Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta-Analysis.
- 1 Nov 2025
- Helicobacter
FAQs on Helicobacter
How long has Helicobacter been actively publishing? 
What is the publishing frequency of Helicobacter?
How many articles did Helicobacter publish last year?
What is the eISSN & pISSN for Helicobacter?
What is Citescore for Helicobacter?
What is the H Index for Helicobacter ?
What is SNIP score for Helicobacter?
What is the SJR for Helicobacter?
Who is the publisher of Helicobacter?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations